Welcome to LookChem.com Sign In|Join Free

CAS

  • or

110928-45-5

Post Buying Request

110928-45-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

110928-45-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 110928-45-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,9,2 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 110928-45:
(8*1)+(7*1)+(6*0)+(5*9)+(4*2)+(3*8)+(2*4)+(1*5)=105
105 % 10 = 5
So 110928-45-5 is a valid CAS Registry Number.

110928-45-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name cis-4-Hydroxymethyl-cyclohexanecarboxylic acid methyl ester

1.2 Other means of identification

Product number -
Other names METHYL CIS-4-HYDROXYMETHYLCYCLOHEXANE-1-CARBOXYLATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:110928-45-5 SDS

110928-45-5Downstream Products

110928-45-5Relevant articles and documents

STAT DEGRADERS AND USES THEREOF

-

Paragraph 00780; 00781, (2021/09/26)

The present invention provides compounds, compositions thereof, and methods of using the same.

NK1 RECEPTOR ANTAGONIST

-

Paragraph 0098, (2018/11/21)

A problem of the present invention is to provide a new compound which has NK1 receptor antagonist activity, and thus is useful for the prevention or treatment of cancer-chemotherapy-induced nausea and vomiting. A compound represented by the formula (I): wherein W represents a fluorine atom and the like, ring A represents a cycloalkyl and the like, X1 represents CH or N, R represents methyl and the like, Y represents 0 to 2, U1, U2 and U3 each independently represents a single bond and the like, or a pharmaceutically acceptable salt thereof. The compounds of the present invention or pharmaceutically acceptable salts thereof have an excellent NK1 receptor antagonist activity, and thus are also useful as an agent for the prevention or treatment of cancer-chemotherapy-induced nausea and vomiting.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 110928-45-5